Bioimpacts

7.3k citations
455 papers · · active since 2014

Impact in

Papers in

Bioimpacts

414 papers receiving 7.2k citations

Peers

Bioimpacts
Comparison fields: 5 of 176
  • Drug Discovery 24
  • Pharmaceutical Science 562
  • Biomaterials 917
  • Molecular Medicine 250
  • Molecular Biology 1.3k
Replace Current Drug Discovery Technologies with:
Current Drug Discovery Technologies India
Journal of Applied Biomedicine Czechia
Drug Discoveries & Therapeutics Japan
Bioinorganic Chemistry and Applications India
The EPMA Journal China
Nano Biomedicine and Engineering China
Journal of Nanomedicine & Nanotechnology United States
Journal of Toxicology United States
Biotechnology and Genetic Engineering Reviews China
Pharmaceutica Acta Helvetiae Switzerland
Bioimpacts relative to Current Drug Discovery Technologies India Current Drug Discovery Technologies's profile →
Citations per field
00.5×1.5×
Current Drug Discovery Technologies · 1×
Citations per year

Countries where authors publish in Bioimpacts

Since Specialization
Citations

This map shows the geographic impact of research published in Bioimpacts. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Bioimpacts with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bioimpacts more than expected).

Fields of papers published in Bioimpacts

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Bioimpacts. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Bioimpacts.

About Bioimpacts

The 455 papers published in Bioimpacts in the last decades have received a total of 7.3k indexed citations . Papers published in Bioimpacts usually cover Pharmaceutical Science (29 papers), Drug Discovery (1 paper), Biomaterials (41 papers), Genetics (21 papers) and Molecular Medicine (11 papers) specifically the topics of Nanoparticle-Based Drug Delivery (30 papers), Bone Tissue Engineering Materials (21 papers), Mesenchymal stem cell research (19 papers), Computational Drug Discovery Methods (18 papers), Advanced Drug Delivery Systems (14 papers), MicroRNA in disease regulation (11 papers), Extracellular vesicles in disease (11 papers) and Tissue Engineering and Regenerative Medicine (11 papers). The most active scholars publishing in Bioimpacts are Yadollah Omidi, Jaleh Barar, Srinivasan Shanmugam, Abolghasem Jouyban, Mohammad Mostafa Pourseif, Khalil Ansarin, Mohammad A. Rafi, Maryam Khoubnasabjafari, Marziyeh Fathi and Ayuob Aghanejad.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore journals with similar magnitude of impact